Lacutamab Biosimilar - Anti-KIR3DL2 Antibody - Low endotoxin, Azide free (A323526)

Lacutamab Biosimilar - Anti-KIR3DL2 Antibody - Low endotoxin, Azide free

Recombinant human monoclonal antibody to KIR3DL2.

ELISA, FACS, Functional Assay, In Vivo

Human, Mouse, Rabbit

Human

Monoclonal

IgG1

kappa

Unconjugated

Protein A affinity chromatography.

Reconstitution dependent.

> 95% (by SDS-PAGE and SEC-HPLC).

Lyophilized

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

CD158 antigen like family member K, CD158 antigen-like family member K, CD158k, KI3L2_HUMAN, Killer cell immunoglobulin like receptor 3DL2, killer cell immunoglobulin like receptor KIR3DL2, Killer cell immunoglobulin like receptor, three domains, long cytoplasmic tail, 2, Killer cell immunoglobulin-like receptor 3DL2, KIR antigen 3DL2, Kirl2, MHC class I NK cell receptor, Natural killer associated transcript 4, natural killer cell inhibitory receptor, Natural killer-associated transcript 4, NK associated transcript 4, NK associated transcript 4A, included, NK associated transcript 4B, included, NKAT-4, NKAT4, NKAT4B, p140, p70 natural killer cell receptor clone CL 5, p70 natural killer cell receptor clone CL-5, p70 NK receptor CL 5, p70 NK receptor CL-5